Germitec Awarded Specialty High-Level Ultrasound Probe Disinfection Equipment Category Agreement with Premier, Inc.San Diego, California and Bordeaux, France, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Germitec, a pioneering MedTech company specializing in High-Level Disinfection (HLD) for ultrasound probes through its unique patented Yuvee® technology, has been awarded a national group purchasing agreement with Premier, Inc. Effective March 1, 2026, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Germitec’s Chronos® UV-C High-Level Disinfection device.
Germitec Secures $30 Million Financing to Accelerate U.S. Market Expansion and Drive Innovation in UV-C High-Level Disinfection
Germitec, a leading MedTech company specializing in UV-C High-Level Disinfection solutions, has announced the successful closing of a $30 million financing round. The funding will enable the company to accelerate its development in the U.S. market and continue pioneering advancements in UV-C infection prevention technologies.
The US Food and Drug Administration Grants First-Ever De Novo (Ultraviolet radiation disinfection chamber device) for Germitec’s Chronos®, a Chemical-Free UV-C High-Level Disinfection (HLD) Device for Endocavitary and External Ultrasound Probes
Germitec, an innovative French MedTech company specializing in High-Level Disinfection (HLD) for ultrasound probes through its unique proprietary UV-C technology, is pleased to announce that the FDA has granted first-ever De Novo for its Chronos® automated disinfection device.
